Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease
Open Access
- 1 February 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 27 (2) , 267-275
- https://doi.org/10.1016/s0741-5214(98)70357-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cilostazol Has Beneficial Effects in Treatment of Intermittent ClaudicationCirculation, 1998
- Value of a supervised exercise program for the therapy of arterial claudicationJournal of Vascular Surgery, 1997
- Exercise training improves functional status in patients with peripheral arterial diseaseJournal of Vascular Surgery, 1996
- Epidemiology of Peripheral Arterial DiseaseJournal of Cardiovascular Pharmacology, 1994
- Benefit of exercise conditioning for patients with peripheral arterial disease.Circulation, 1990
- Current Therapy of Peripheral Obstructive Arterial Disease. The Non-Surgical ApproachAngiology, 1990
- Diagnostic methods for peripheral arterial disease in the san luis valley diabetes studyJournal of Clinical Epidemiology, 1989
- Another Look at the Pentoxifylline Efficacy Data for Intermittent ClaudicationThe Journal of Clinical Pharmacology, 1987
- The prevalence of peripheral arterial disease in a defined population.Circulation, 1985
- Pentoxifylline efficacy in the treatment of intermittent claudication: Multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patientsAmerican Heart Journal, 1982